Thanks! I think the focus will be away from the lawsuit and insider selling and more on their new ID apps. We can even take our eyes off of MD because it seems a given to be increasing 30 to 40% a year.
We have a former CEO of Master Card international on the board, a Harvard CEO and a big opportunity in a huge market ahead. Identity solutions really plays to the core strengths and competencies of Mitek stretching back over the decades with the US govt and really blooming lately with MD and the ID checker acuisition. Could be a game changer for months to come and beyond. Hoping to exceed old highs. Just keep holding, imo.
If you check SSRI, Zacks has a word for word form letter write up on them.
But I'm expecting gains as the revs rise steadily. New products could be the blockbuster we've been looking for to follow up on MD.The Insider selling has been going on all along .It's understandable.It will subside.Debello actually has added to his holdings, net. The lawsuits are behind them.
The sky is looking blue and I'm planning to hold this to$12 and beyond.
I think people will be verifying there ID via selfies in the future in order to transact via their beloved smart phones. I think it will be international and bigger than MD. MITK may be positioned to cash in on yet another exploding social phenomenon.
They are self financing Clearpath so they haven't had to sell anyone on it's merits except for themselves, really. I've seen no big insider buys or professional capital plunking down money on this plan. Former CEO bought some and they have the share buy back. Getting a qualified CEO to commit would help.The fact that insiders own 28% means there is skin on the game. I'm still holding.
I think some of the issues brought up by the author will be addressed in the next CC. It will be interesting to see if they can get a well qualified CEO on board.
I'm still holding. DYSL needs to see some funds released from sequester. DYSL has a good backlog but could use the cash payments. Maybe these are the types of movement they need- check this:
The House Appropriations Committee approved the last of its 12 appropriations bills for Fiscal Year 2016 Tuesday, voting 32-17 to send the Homeland Security appropriations bill to the House floor for a final vote.
“With the approval of the 12th bill today, all committee work on funding measures is completed — the first time this has happened since 2009 — and this has been done at a rapid pace with several weeks left before the August recess,” Appropriations Chairman Hal Rogers (R-Ky.) said, at the end of the markup session. “In addition, six Appropriations bills have been approved by the full House. I congratulate the Committee on this impressive work.”
The bill provides the Homeland Security Department with $39.3 billion in discretionary funding for FY 2016. That’s $337 million less than what DHS received in FY 2015 and $2.1 billion under what President Barack Obama asked for ...
The 5 yr chart shows it going from under $1 in 2011 to $2.50 in 2014, pulling back to $1.50 and rallying to $1.83 today and making very bullish chart with a golden cross, a huge run up and a pullback to the 200dma along with a successful test and a big volume move into bullish territory above the up- sloping 50 and 200dma,
"If ITI no longer has to invest $6M or so a year in iperform and gets $20M in revs from these new investments in iperform and gets 80-85% margin on those revs and you run the numbers, the EBITDA per year could be close to the entire EV right now.
But this is what they envision over next 2 or 3 years! They are hoping for revs that rival other sectors of business which run about $30m.
So this stock could be dead money for a while. It could really be "watching grass grow" test of patience. But if it should happen to unfold as they hope it will , it could start earning $.70 a share as opposed to the .01 they have been making recently. Could go to $18, imo. And precision Ag and weather analytics is faster growth for forseeable future.
My hope is that in about 6mos the PPS starts climbing decently.
...If I see insider buying or institutional interest soon I will probably double my shares. Otherwise I'll stand pat."
ABOVE is a copy of my post 6 months ago 1-21-2015
**insider own 28% of outstanding**
Purchased at $1.47 in 2010
Last year saw record revenue and an increase in gross margin. The growth of the backlog by 10 per cent bodes well for future results. A return to profitability appears in the cards. Insiders own about 28 per cent. Initial Sell Target - $3.49
There is a video on this and it's WELL worth finding. He likes the balance sheet. He was questioned about the way it hasn't gone anywhere and he had a good answer for that. If you cannot find the video I'll try to post a link or some way to find it.
The Senate late on July 27 agreed to limit debate on a six-year highway bill, paving the way for final passage within days. The bill, which includes a provision calling for the reauthorization of the Export-Import Bank, would keep highway programs funded for the first three years of authorization.
7-9-2015. Google it.
Wynnfielld Partnersl took profits on 450K shares in 12-2014 but still hold 1.2 M shares. Meanwhile insiders have bought about 130K shares at around today's price. I like that they are buying right after the DCI deal.
ARTH just did a private placement for $3m to help fund human trials. DYSL seems to be a much better investment and the market cap comparison between the two is a head scratcher. DYSL now calls the patch ONESTOP.http://www.xcedetech.com/
They were stuck in the $5.5M range for last 3 Q's.
Now it's $6.4 and next Q should be near $7M. This is great.
New acquisition has international reach and it's looking less and less like a one trick pony. Short squeeze and no resistance till 200dma and then a clean shot at $6.50,imo.
$6.4! This is getting into hockey stick territory. Very nice. Going up!! Pushing a 40% growth rate! Could see some institutions returning to this stock.
Blows away estimates.
Mitek up 7.8% on FQ3 beat, guidance hike
Jul 23 2015, 17:24 ET | About: Mitek Systems Inc. (MITK) | By: Eric Jhonsa, SA News Editor Contact this editor with comments or a news tip
With an FQ3 beat in tow, Mitek (NASDAQ:MITK) is hiking its FY15 (ends in September) sales guidance by $1M to $23.5M-$24.5M, above a $23.1M consensus.Mitek's mainstay Mobile Deposit solution is now licensed by over 4K financial institutions, up from 3,705 at the end of FQ2. Software revenue +47% Y/Y to $4.68M; services +19% to $1.76M.Sales/marketing spend fell 9% Y/Y to $1.65M; R&D fell 15% to $1.35M, and G&A 22% to $1.8M. Mitek ended FQ3 with $24M in cash/short-term investments, and no debt. The deferred revenue balance stood at $4M
Checking through the Conservis web site and clicking on "News", I notice a PR dated 11-2014 where they had $6B in assets under management. Now they boast a 33% increase.
To have exposure to an area that can have that kind of growth is significant,IMO.
I like the deal. Each new relationship helps ITI to become a more recognized and more credible big data supplier. Hopefully we'll hear, in next CC, how they may monetize this.
If I see any insider or institutional buying I'll probably double what I have. But I'm liking this PR.
Still here for long haul now.
A lot of gov't funds were approved for DYSl projects but funds were sequestered. Would be nice to see them released. They are still investing on Dichro and expecting it to pay off with ROI if investors can have a little more patience.
Another $.4m per Q (only for the next Q) is going into some other product development that I'm sure they would not part with if they did not expect imminent ROI. I'm quite sure it WILL happen.
CLYC is kicking in as I type and will contribute about $1m a year on a steady recurring basis.
The money they put into the Xcede patch punishes profits a bit but there is value created as the possible selling price goes up. So the financial statements only show the expense. Not the value being created by the expense, I think.
If the ROI on the other investments and CLYC come together, I'm hoping for gains even without Xcede news.
They do need to eventually sell it or get a major investor to relieve the expense from the income statement but there are a lot of moving parts that go into assessing DYSL as an investment, so i'll just hold it.